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women compared with 2007.3 Prostate 
cancer is the most common cancer in males, 
followed by lung and colorectal. For women 
breast cancer is the most common followed 
by lung and colorectal. Lung cancer is the 
number one cancer killer for both men and 
women. 
There is much evidence which shows 
that about 40% of all cancer cases are 
preventable (Table 1). In fact prevention 
offers the most cost-effective long-term 
strategy for the control of cancer. Lifestyle 
factors continue to be causally related 
to certain cancers including tobacco 
use, unhealthy diet, alcohol overuse and 
inadequate physical activity.4 
Secondary prevention measures include 
screening. Screening for cancer involves the 
application of a simple test in a healthy 
asymptomatic population to identify early 
disease. The main objective of cancer 
screening (and subsequent treatment) is to 
shift the stage at which disease presents 
thus extending life and reducing cancer 
mortality. Other important considerations 
include the economic cost and the potential 
effects on quality of life, which may be 
beneficial or harmful. Screening may induce 
adverse effects, such as over-diagnosis and 
over-treatment and generation of undue 
anxiety. Screen detected cases may include 
indolent lesions, some of which would not 
progress even if untreated.5,6
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Educational aims
Introduction
Cancer is a leading cause of death worldwide 
and accounted for 7.6 million deaths (around 
13% of all deaths) in 2008. The number of 
global cancer deaths is projected to increase 
by 45% from 2007 to 2030 (from 7.9 million 
to 11.5 million deaths), influenced in part by 
an increasing and aging global population. 
The estimated rise takes into account 
expected slight declines in death rates for 
some cancers in high resource countries. 
New cases of cancer in the same period are 
estimated to jump from 11.3 million in 2007 
to 15.5 million in 2030.1
The incidence rate of new cases of cancer 
in Malta is on the increase however the 
number of deaths from cancer are on a down 
going trend (Figure 1 ) especially for some 
forms of cancer including breast cancer.2 This 
reflects improvements in early detection and 
treatment. 
A recent study has estimated that 
the number of cancer-related deaths 
in EU member states for 2011 will 
be nearly 1.3 million. Using a new 
mathematical model, the predictions 
show that cancer mortality rates should 
fall around 7% for men and 6% for 
67% of mouth, pharynx and larynx cancers
75% of cancers of the oesophagus
33% of lung cancers
45% of stomach cancers
41% of pancreatic cancer
16% of gallbladder cancer
43% of bowel cancer
17% of liver cancer
42% of breast cancer
56% of endometrial cancer
20% of prostate cancer
19% of kidney cancer
39% of these 12 cancers combined and 
26% of all cancers
Table 1: Preventable Cancers
Cancer is the leading cause of death worldwide. Evidence shows 
that about 40% of all cancers are preventable. This article looks at 
the evidence base for primary prevention measures focusing on 
lifestyle risk factors of tobacco exposure, overweight and obesity, 
dietary factors, alcohol and physical activity. Some basic principles of 
screening and screening programmes are discussed with emphasis on 
the importance of doing more benefits than harms, at a reasonable 
cost. We look at the evidence for effectiveness of cancer screening 
programmes, including randomized controlled trials and touch briefly 
on the ongoing debates for and against the effectiveness of organized 
screening programmes. Sufficient evidence exists to demonstrate the 
effectiveness of screening for breast, colorectal and cervical cancer. 
Ongoing studies in prostate screening will provide valuable evidence 
in due course.
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Effectiveness of screening is measured 
in terms of mortality reduction – this is 
what motivates public health policy makers 
to implement, manage and evaluate cancer 
screening programmes.7
Primary Prevention Measures 
Tobacco 
Tobacco is the single largest cause of 
preventable cancer in the world.8 It is 
responsible for 1.8 million cancer deaths 
per year and causes 80-90% of all lung 
cancer deaths, and also causes a number of 
deaths from cancer of the oral cavity, larynx, 
oesophagus and stomach.9 Tobacco smoke 
contains about 4000 different chemicals, 
of which at least 80 of these could cause 
cancer.10 
Tobacco smoke was first shown to cause 
lung cancer in 1950 by Doll and Hill.11 
Decades of research have consistently 
established the strong association between 
tobacco use and cancers of many sites. 
Specifically, cigarette smoking has been 
established as a cause of cancers of the 
lung.8 Studies have shown that lung cancer 
risk is greatest amongst those who smoke 
the most cigarettes over the longest period 
of time.12 Starting smoking at an early 
age increases the cancer even more than 
starting later in life.13 Tobacco is a major 
risk factor for several other types of cancer 
including oral cavity, oesophagus, bladder, 
kidney, pancreas, stomach, cervix, and acute 
myelogenous leukemia.14,15,16,17 Second-hand 
smoke, also known as environmental tobacco 
smoke, has been proven to cause lung cancer 
in nonsmoking adults.18 
Smoking avoidance and smoking 
cessation result in decreased incidence and 
mortality from cancer. Stopping smoking at 
50 years of age would half the excess risk of 
overall cancer , whilst stopping at 30 years 
of age would avoid the majority of cancer.19 
The effects of quitting smoking depend on 
the type of cancer.20,21
Overweight and obesity 
Cancer of the colon,22 breast 
(postmenopausal),23 endometrium,24 kidney,25 
oesophagus,26 are associated with obesity. 
Some studies have also reported associations 
of obesity with cancer of the gallbladder, 
ovaries and the pancreas.27 The risk of 
postmenopausal breast cancer in obese 
women is 1.5 times the risk of women of 
healthy weight. 28,29 This led to a number 
of studies related to the risk reduction in 
persons who were overweight or obese by 
intentional weight loss. A recent study found 
that women who experienced intentional 
weight loss of 20 or more pounds and were 
not currently overweight, had cancer rates 
at the level of non overweight women who 
never lost weight.30 These findings suggest 
that intentional weight loss might reduce 
risk of obesity-related cancers. Therefore this 
adds on the importance that overweight and 
obese people will gain health benefits by 
losing weight.
Diet 
Apart from the link between overweight and 
obesity, which is related to diet, there is also 
some evidence that diet has an effect on 
cancer. Estimates concerning the potential 
contribution of diet to the population 
burden of cancer have varied widely. The 
exact association between diet and cancer 
development has not been firmly established. 
In contrast to the epidemiologic evidence on 
cigarette smoking and cancer, evidence for 
the influence of dietary factors and cancer 
is uncertain. An assessment of the potential 
role of diet entails measuring the net 
contribution of diets, comprising factors that 
may protect against cancer and other factors 
that may increase cancer risk. 
Various reviews,31have shown that the 
greatest consistency was seen for fruits and 
non-starchy vegetables. They were associated 
with “probable decreased risk” for cancers 
of the mouth, esophagus, and stomach. 
Fruits, but not non-starchy vegetables, were 
also found be associated with “probable 
decreased risk” of lung and bladder cancer 
32,33. Vegetables may also have a protective 
effect against ovarian cancer.34 
Literature suggests that eating a 
variety of foods containing high fiber 
has a protective effect against colon 
cancer. Evidence also indicates that a high 
fiber-containing diet may be protective 
against breast, ovary, endometrial, and 
gastrointestinal cancer. However, it is 
difficult to assess if the protection is clearly 
Figure 1: Incidence (left) and mortality rates (right) of Cancer in Malta compared to UK and EU average
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from fiber or some other dietary component, 
such as low fat.35 A randomized controlled 
trial of supplemental wheat bran fiber did not 
reduce the risk of subsequent adenomatous 
polyps in individuals with previously resected 
polyps. Hence for cancer prevention, the 
emphasis for dietary recommendation should 
be on a dietary pattern rather than on an 
isolated dietary fiber supplement.36 
Ecologic, cohort, and case-control 
studies found an association between fat and 
red meat intake and colon cancer risk,37 but 
a randomized controlled trial of a low-fat 
diet in postmenopausal women showed no 
reduction in colon cancer.38
Alcohol 
Alcohol use is a risk factor for many 
cancer types including cancer of the oral 
cavity, pharynx, larynx, oesophagus, liver, 
colorectum and breast. In fact WHO have 
estimated that harmful alcohol use is 
responsible for 351 000 cancer deaths per 
year globally. Risk of cancer increases with 
the amount of alcohol consumed.39 The 
risk from heavy drinking for several cancer 
types (e.g. oral cavity, pharynx, larynx and 
oesophagus) substantially increases if the 
person is also a heavy smoker. Attributable 
fractions vary between men and women 
for certain types of alcohol-related cancer, 
mainly because of differences in average 
levels of consumption. For example, 22% of 
mouth and oropharynx cancers in men are 
attributable to alcohol whereas in women the 
attributable burden drops to 9%. A similar 
gender difference exists for oesophageal and 
liver cancers.40
Physical activity 
A growing body of epidemiologic evidence 
suggests that people who are more 
physically active have a lower risk of certain 
malignancies than those who are more 
sedentary. 41 It has been established that 
there is a “probable” association of physical 
activity with lower risk of postmenopausal 
breast cancer,42 and colon cancer.43 Some 
evidence also shows a link with lower risk of 
endometrial44 and prostate cancer 45. As with 
the dietary factors described above, physical 
activity seems to play a more prominent role 
in selected malignancies. 
Secondary prevention by screening 
“All screening programmes do harm; some 
also do good. The responsibility of the 
policy-maker is to decide which programmes 
do more good than harm at reasonable cost 
and then introduce them, once they are 
confident that the screening programme 
can and will reach the standard of quality 
required for success.” 46
Appraising the evidence -  
the effectiveness of screening
A screening programme should have high 
sensitivity and specificity. Sensitivity is the 
capacity to detect cases in the pre-clinical 
detectable phase amongst those screened. 
Specificity is the ability to correctly identify 
subjects without the disease. Other measures 
of performance include screening attendance, 
reproducibility of screening test, diagnostic 
procedures used to confirm positive screens 
and interval between successive screening 
tests.47
A randomized controlled trial (RCT), with 
mortality as its end-point, is still considered 
as the optimal and often the only valid 
means of evaluating the effectiveness of 
a screening programme. Cohort and case-
control studies are often used, and most 
evidence comes from comparisons of time 
trends and geographical differences between 
populations that were subjected to screening 
of variable intensity. Non-experimental 
studies do not provide a solid basis for 
decision making. 48
The criteria developed by Wilson and 
Jungner,49 have stood the test of time well 
and are still useful today. There have since 
been broad debates stimulated by the 
evidence-based decision making movement 
and the Cochrane collaboration. In a 
hierarchy of evidence, a systematic review of 
randomized controlled trials is usually placed 
at the top. However, disputes remained 
unresolved, because value judgments are 
involved in the selection or rejection of trials 
to be included in the systematic review. 
This was most fiercely argued in the debate 
about breast cancer screening when a review 
in The Lancet suggested that the evidence 
for screening was biased by the inclusion of 
trials of low quality.50 An extensive exchange 
of letters took place until the issue was 
reviewed by IARC, the International Agency 
for Research on Cancer, which published 
a report concluding that: “…trials have 
provided sufficient evidence for the efficacy 
of mammography screening of women 
between 50 and 69 years. The reduction in 
mortality from breast cancer among women 
who chose to participate was estimated to 
be about 35%...”51 
The effectiveness of screening for breast 
(mammography), colorectal (FOBT) and 
cervical cancer (Pap smear) have now been 
firmly established.6 Although limitations 
in the existing evidence base include 
insufficient evidence about harm and the 
need to address opportunity costs.7
Introduction of the HPV vaccine may 
reduce the demand for cervical cancer 
screening by decreasing the risk of disease, 
but this will take a considerable amount 
of time to be seen. Screening for prostate 
cancer has not been fully evaluated but 
ongoing RCTs should provide important 
evidence in due course.52 Evidence of 
effectiveness of screening for other cancers 
remains insufficient or unclear.
Conclusion
Prevention is the key to reducing the 
burden that cancers have on our health 
care systems. Regular physical activity and 
the maintenance of a healthy body weight, 
along with a healthy diet, and avoidance of 
tobacco will considerably reduce cancer risk. 
Key Practice Points 
•	 Many aspects of general health can be improved, and many cancer deaths prevented, if 
people adopt healthier lifestyles (adopted from European Cancer Code 2003).
•	 Tobacco	should	be	avoided	completely.	Assistance	is	available	to	help	people	quit	 
in the form of counselling and group sessions.
•	 Obesity	is	a	risk	factor	and	needs	to	be	controlled.	Physical	activity	on	a	daily	basis	
helps prevent weigth gain and is directly related to cancer prevention. A healthy diet 
with vegetables and fruits and decreased consumption of foods containing fats from 
animal sources are proven beneficial to prevent cancer. Alcohol can only be consumed 
in moderation. 
•	 Exposure	to	sun	and	cancer	causing	substances	should	be	avoided.	
•	 Public	health	programmes	that	could	prevent	cancers	developing	or	increase	the	
probability that a cancer may be cured include breast, cervical and colorectal screening. 
•	 Vaccination	programmes	against	hepatitis	B	virus	infection	can	prevent	cancers	 
of the liver.
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Screening is a programme, not a test. 
Screening programmes mandate a fine and 
dynamic balance between benefits and 
harms. Establishing the benefits of screening 
requires evidence of mortality reduction from 
large randomized trials, as for breast, and 
colorectal cancer. In spite of the lack of RCT 
evidence, screening for cervical cancer with 
cytological smears has been shown to be 
effective. Screening tests are available for 
other cancer types but their efficacy has not 
been demonstrated effectively. Based on this 
evidence, Malta launched the National Breast 
Screening Programme in 2009. The National 
Cancer Plan 2011-15 announced in February 
2011 outlines firm plans for colorectal and 
cervical screening programmes in the near 
future. This is complemented by the Non 
Communicable Disease Strategy launched in 
April 2010, which outlines the basis upon 
which programmes are implemented to raise 
awareness and reduce exposure to cancer 
risk factors, and to ensure that people are 
provided with the information and support 
they need to adopt healthy lifestyles.
